[Preventive effects of diclofenac ophthalmic solution on post-cataract-surgical cystoid macular edema].
Using eyes undergoing phacoemulsification followed by implantation of a foldable acrylic intraocular lens (IOL) designed for small-incision cataract surgery, a multi-center study was performed to compare a non-steroidal ophthalmic solution (0.1% diclofenac) to a steroidal ophthalmic solution (0.1% fluorometholone) in preventing cystoid macular edema (CME) and inducing disruption of the blood-aqueous barrier determined by laser flare cellmetry. The incidence of CME, noted in 3 out of 53 eyes (5.7%) receiving diclofenac and in 29 out of 53 eyes (54.7%) receiving fluorometholone, was significantly lower in the diclofenac group. The flare in the anterior chamber was also significantly lower in the diclofenac group; when compared between eyes with and without CME, the amount of flare was significantly higher in the former group. These findings suggest that diclofenac effectively prevents CME following cataract surgery and that CME is closely related to the breakdown of the blood-aqueous barrier.
Miyake
K
K
Miyake Eye Hospital, Aichi-ken, Japan.
Masuda
K
K
Shirato
S
S
Oshika
T
T
Eguchi
K
K
Hoshi
H
H
Majima
Y
Y
Kimura
W
W
Hayashi
F
F
D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D018916:Blood-Aqueous Barrier / Q000502:physiology; D002387:Cataract Extraction; D004008:Diclofenac / Q000008:administration & dosage*; D005469:Fluorometholone / Q000008:administration & dosage; D006801:Humans; D008269:Macular Edema / Q000517:prevention & control*; D008875:Middle Aged; D009883:Ophthalmic Solutions; D011183:Postoperative Complications / Q000517:prevention & control*
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D009883:Ophthalmic Solutions; D004008:Diclofenac; D005469:Fluorometholone